The highest dose of an experimental drug developed by Eli Lilly significantly reduced levels of a genetically inherited risk ...

The drug's effects lasted six months with no major side effects, according to new research presented in Chicago Sunday at an American College of Cardiology meeting and also published in the New ...

While the drug reduced a cardiovascular risk factor, large trials are needed to prove that lowering Lp(a) actually cuts heart attacks and other adverse cardiovascular events, Nissen said.

Experimental Lilly Drug Cuts Genetic Heart Disease Risk Factor by 94% in Trial By Julie Steenhuysen CHICAGO (Reuters) - The highest dose of an experimental drug developed by Eli Lilly ...